Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in Operable Breast and Lung Cancer
NCT04857697Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial, sponsored by Mayo Clinic. Primary endpoints: Length and adherence of probiotics at 4 weeks, Percentage of CD8+, CD4+, and T-reg cells at 4 weeks and 1 more. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT04857697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04857697.